Skip to main content
VCbacked
Log inGet Started

Ember LifeSciences

Los Angeles, United States

Ember LifeSciences is a healthcare technology company that develops cold chain solutions for transporting temperature-sensitive medicines.

$16.5M raised
May 2026
Series A
BiopharmaHealth CareInformation TechnologyLogisticsPackaging Services

Top Investors

Cardinal HealthSea Court CapitalAmgen VenturesCarrier VenturesTDF Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ember LifeSciences

How much funding has Ember LifeSciences raised?
Ember LifeSciences has raised $16.5M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
Who are Ember LifeSciences's investors?
Ember LifeSciences's investors include Cardinal Health, Sea Court Capital, Amgen Ventures, Carrier Ventures, TDF Ventures.
Where is Ember LifeSciences headquartered?
Ember LifeSciences is headquartered in Los Angeles, United States.
What does Ember LifeSciences do?
Ember LifeSciences is a healthcare technology company that develops cold chain solutions for transporting temperature-sensitive medicines.
What stage is Ember LifeSciences at?
Ember LifeSciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ember LifeSciences — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/ember-lifesciences. Accessed June 3, 2026.
APA
VCBacked. (2026). Ember LifeSciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/ember-lifesciences
Wikipedia (cite web)
{{cite web |title=Ember LifeSciences — Funding & Investors |url=https://www.vcbacked.co/company/ember-lifesciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
ClearNote Health
San Diego
Retro Biosciences
Redwood City